🎉 M&A multiples are live!
Check it out!

Supriya Lifescience Valuation Multiples

Discover revenue and EBITDA valuation multiples for Supriya Lifescience and similar public comparables like Black Diamond Therapeutics, Actuate Therapeutics, and ST Pharm.

Supriya Lifescience Overview

About Supriya Lifescience

Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.


Founded

2008

HQ

India
Employees

448

Financials

LTM Revenue $82.5M

LTM EBITDA $28.5M

EV

$655M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Supriya Lifescience Financials

Supriya Lifescience has a last 12-month revenue of $82.5M and a last 12-month EBITDA of $28.5M.

In the most recent fiscal year, Supriya Lifescience achieved revenue of $64.7M and an EBITDA of $21.5M.

Supriya Lifescience expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Supriya Lifescience valuation multiples based on analyst estimates

Supriya Lifescience P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $52.4M $64.7M XXX XXX XXX
Gross Profit $33.6M $25.6M XXX XXX XXX
Gross Margin 64% 40% XXX XXX XXX
EBITDA $15.9M $21.5M XXX XXX XXX
EBITDA Margin 30% 33% XXX XXX XXX
Net Profit $17.6M $10.4M XXX XXX XXX
Net Margin 34% 16% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Supriya Lifescience Stock Performance

As of April 15, 2025, Supriya Lifescience's stock price is INR 711 (or $8).

Supriya Lifescience has current market cap of INR 57.2B (or $665M), and EV of INR 56.4B (or $655M).

See Supriya Lifescience trading valuation data

Supriya Lifescience Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$655M $665M XXX XXX XXX XXX $0.25

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Supriya Lifescience Valuation Multiples

As of April 15, 2025, Supriya Lifescience has market cap of $665M and EV of $655M.

Supriya Lifescience's trades at 7.9x LTM EV/Revenue multiple, and 23.0x LTM EBITDA.

Analysts estimate Supriya Lifescience's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Supriya Lifescience and 10K+ public comps

Supriya Lifescience Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $655M XXX XXX XXX
EV/Revenue 8.5x XXX XXX XXX
EV/EBITDA 24.5x XXX XXX XXX
P/E 35.7x XXX XXX XXX
P/E/Growth 2.3x XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Supriya Lifescience Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Supriya Lifescience Valuation Multiples

Supriya Lifescience's NTM/LTM revenue growth is 21%

Supriya Lifescience's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $32K for the same period.

Over next 12 months, Supriya Lifescience's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Supriya Lifescience's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Supriya Lifescience and other 10K+ public comps

Supriya Lifescience Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 24% XXX XXX XXX XXX
EBITDA Margin 34% XXX XXX XXX XXX
EBITDA Growth 35% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 55% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $32K XXX XXX XXX XXX
S&M Expenses to Revenue 4% XXX XXX XXX XXX
G&A Expenses to Revenue 4% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 22% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Supriya Lifescience Public Comps

See public comps and valuation multiples for Small Molecules comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Race Oncology XXX XXX XXX XXX XXX XXX
Ascentage Pharma Group XXX XXX XXX XXX XXX XXX
ST Pharm XXX XXX XXX XXX XXX XXX
Actuate Therapeutics XXX XXX XXX XXX XXX XXX
Black Diamond Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Supriya Lifescience M&A and Investment Activity

Supriya Lifescience acquired  XXX companies to date.

Last acquisition by Supriya Lifescience was  XXXXXXXX, XXXXX XXXXX XXXXXX . Supriya Lifescience acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Supriya Lifescience

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Supriya Lifescience

When was Supriya Lifescience founded? Supriya Lifescience was founded in 2008.
Where is Supriya Lifescience headquartered? Supriya Lifescience is headquartered in India.
How many employees does Supriya Lifescience have? As of today, Supriya Lifescience has 448 employees.
Is Supriya Lifescience publicy listed? Yes, Supriya Lifescience is a public company listed on BOM.
What is the stock symbol of Supriya Lifescience? Supriya Lifescience trades under 543434 ticker.
When did Supriya Lifescience go public? Supriya Lifescience went public in 2021.
Who are competitors of Supriya Lifescience? Similar companies to Supriya Lifescience include e.g. Race Oncology, Ascentage Pharma Group, ST Pharm, Actuate Therapeutics.
What is the current market cap of Supriya Lifescience? Supriya Lifescience's current market cap is $665M
What is the current revenue of Supriya Lifescience? Supriya Lifescience's last 12-month revenue is $82.5M.
What is the current EBITDA of Supriya Lifescience? Supriya Lifescience's last 12-month EBITDA is $28.5M.
What is the current EV/Revenue multiple of Supriya Lifescience? Current revenue multiple of Supriya Lifescience is 7.9x.
What is the current EV/EBITDA multiple of Supriya Lifescience? Current EBITDA multiple of Supriya Lifescience is 23.0x.
What is the current revenue growth of Supriya Lifescience? Supriya Lifescience revenue growth between 2023 and 2024 was 24%.
Is Supriya Lifescience profitable? Yes, Supriya Lifescience is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.